Medication info

Invivita D Injection (Cholecalciferol)

Prescription medicationInjectionsIntramuscular injectionExpired
Ingredient · strength
Cholecalciferol Concentrate Oil›200mg / 1mL
Manufacturer / importer
Vivozon Pharmaceutical Co., Ltd.
Appearance
A brown ampoule containing a colorless, transparent liquid with no odor and a light yellow color.
Packaging
1mL/ampoule X 10
Approval status
Expired

MFDS item code 201804396 · Approved 2018.11.06

This product's status changed to Expired on 2023.11.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Prevention and treatment of vitamin D deficiency
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, adjusting the dose after checking the blood 25-hydroxyvitamin D level. In adults, treatment efficacy and tolerability should be reviewed within 3 months after administration of this drug; in adolescents, they should be reviewed within 6 months. Based on this review, determine whether to administer another dose. Since adverse reactions increase with overdose, do not administer more than the required amount. - Adults: Intramuscularly inject 200,000IU of cholecalciferol. - Older adults: Intramuscularly inject 100,000IU of cholecalciferol. Ensure that the annual dose does not exceed 600,000IU of cholecalciferol.
Child administration
- Adolescents: Intramuscularly inject 200,000IU of cholecalciferol.

Ingredients

Manufacturer
Vivozon Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention and treatment of vitamin D deficiency

View approved original text

This medication is used to prevent and treat vitamin D deficiency in elderly people, adolescents, and adults with vitamin D deficiency.

How it is given

Adult administration

Use as prescribed by a physician, adjusting the dose after checking the blood 25-hydroxyvitamin D level. In adults, treatment efficacy and tolerability should be reviewed within 3 months after administration of this drug; in adolescents, they should be reviewed within 6 months. Based on this review, determine whether to administer another dose. Since adverse reactions increase with overdose, do not administer more than the required amount. - Adults: Intramuscularly inject 200,000IU of cholecalciferol. - Older adults: Intramuscularly inject 100,000IU of cholecalciferol. Ensure that the annual dose does not exceed 600,000IU of cholecalciferol.

Child administration

- Adolescents: Intramuscularly inject 200,000IU of cholecalciferol.

Precautions

This medicine contains vitamin D, so it is important to check the total vitamin D content when taking it with vitamin D fortified foods or other vitamin D preparations. Calcium levels in the blood should be regularly checked, and the medication should be discontinued if calcium levels become too high. If calcium intake is high, it is important to frequently monitor calcium levels in the blood and urine. This medication should not be used in patients with certain diseases, those with poor kidney function, or women who are pregnant or breastfeeding. Various side effects such as headaches, muscle pain, gastrointestinal disturbances, dehydration, and hypertension may occur, so if any abnormal symptoms arise, consult a doctor immediately. When administering to patients with vitamin D deficiency, blood vitamin D levels should be periodically checked, and overdose should be avoided. Patients with impaired kidney function or the elderly should regularly undergo kidney function tests, and dosage adjustments should be made if necessary. As interactions with other drugs may occur, consult a doctor or pharmacist if taking anticonvulsants, diuretics, antacids, etc. together. During pregnancy, excessive intake of vitamin D can be harmful to the fetus, so it is safest not to use this medication. For children under 12 years of age, safety and efficacy have not been adequately confirmed, so it is recommended not to use this medication. In case of overdose, stop taking the medication immediately, reduce calcium intake, increase fluid intake, and treatment to promote diuresis may be necessary. This medication should not be mixed with other drugs, and once the ampoule is opened, it should be used quickly, and any remaining medication should be discarded. Store in a light-resistant, opaque sealed container and keep at a cool temperature between 1 and 25 degrees Celsius to maintain the effectiveness and safety of the medication.

Side effects

headache, weakness, fatigue, muscle pain, loss of appetite, weight loss, stunted growth, nausea, vomiting, constipation, diarrhea, polydipsia, polyuria, dehydration, hypertension, calcium stones, calcification of kidney and vascular tissues, renal impairment, excessive bone calcification, arrhythmia, mental symptoms, awareness disorders, joint pain, myasthenia, drowsiness, azotemia, hypersensitivity reactions, thirst, confusion, gas distension, abdominal pain, metallic taste, dry mouth, rash, itching, hypercalciuria, hypercalcemia, hyperphosphatemia, hyperphosphaturia, injection site granuloma, injection site nodule, injection site reactions, injection site urticaria, injection site infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a light-tight, opaque sealed container. Additionally, it is advisable to store the medication at a cool temperature between 1 and 25 degrees Celsius. This way of storage helps maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

A brown ampoule containing a colorless, transparent liquid with no odor and a light yellow color.

Package unit

1mL/ampoule X 10

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.